Format

Send to

Choose Destination

See 1 citation found by title matching your search:

J Hosp Infect. 2019 Feb;101(2):163-166. doi: 10.1016/j.jhin.2018.08.008. Epub 2018 Aug 10.

Carbapenemase-producing Enterobacteriaceae in Australian hospitals: outcome of point-prevalence screening in high-risk wards.

Author information

1
Victorian Healthcare Associated Infection Surveillance System (VICNISS) Coordinating Centre at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia. Electronic address: judy.brett@mh.org.au.
2
Victorian Healthcare Associated Infection Surveillance System (VICNISS) Coordinating Centre at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia.
3
Microbiological Diagnostic Unit Public Health Laboratory, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia; Department of Health and Human Services, Victoria, Australia.
4
Microbiological Diagnostic Unit Public Health Laboratory, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia.
5
Department of Health and Human Services, Victoria, Australia.
6
Victorian Healthcare Associated Infection Surveillance System (VICNISS) Coordinating Centre at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia; University of Melbourne, Department of Medicine, Victoria, Australia.

Abstract

Carbapenemase-producing Enterobacteriaceae (CPE) infections are increasingly reported in Australian hospitals, but prevalence is unknown. In 2016, Victorian hospitals conducted CPE point-prevalence surveys in high-risk wards (intensive care, haematology, transplant). Forty-three hospitals performed 134 surveys, with 1839/2342 (79%) high-risk patients screened. Twenty-four surveys were also performed in other wards. Inability to obtain patient consent was the leading reason for non-participation. In high-risk wards, no CPE cases were detected; three cases were identified in other wards. Since there is low prevalence in high-risk wards, continuous screening is not recommended. Targeted screening may be enhanced by review of patient consent processes.

KEYWORDS:

Australia; Carbapenemase-producing Enterobacteriaceae; Prevalence; Surveillance

PMID:
30102948
DOI:
10.1016/j.jhin.2018.08.008
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center